Posted in | News

Malvern to Present Latest Stats on Modified Asphalt Usage in the US

Rheology specialists from Malvern Instruments will present the very latest statistics about modified asphalt use in the United States at the 12th annual conference of AMAP - the Association of Modified Asphalt Producers. The conference takes place in Kansas City, MO, from 15 - 17 February 2011.

Details of the survey will be presented as part of the main conference program by John Casola, Products Sales Manager at Malvern Instruments, who will also be one of the instructors at an opening day workshop covering “An introduction to modified asphalt binder and emulsion technology ”. This practical session will look at how best to characterize modified asphalts, and will include details of new rheological tests for the determination of hot mix asphalt mixing and compaction temperatures.

“I am delighted to be able to share the data we have collected this year,” said John Casola. “Maintaining a thorough understanding of the markets we serve is important to Malvern, so we anticipate the needs of our customers and tailor the technical, applications and service support we deliver. The marketing survey I conduct each year, with the support of participating Departments of Transportation and AMAP members, shows how modified asphalt use is changing across the US.”

The survey is in its eighth year and follows an established format designed to facilitate data mining. Information provided from the States includes: a breakdown of the market by modifier type; details of the most common binders used; reasons for the specification of a modified binder; and figures for the use of Plus specifications, as well, as volume forecasts for the next year.

AMAP is a not-for-profit organization comprised of industry leaders involved with all aspects of the modified asphalt market. To find out more about the conference or register for attendance visit: www.modifiedasphalt.org

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.